-transparent.png){kind=logo}
The interaction between hyperthermia and a DNA topoisomerase I inhibitor, 7-ethyl-10-(4-(1-piperidyl)-1-piperidyl)-carbonyloxy- camptothecin (CPT-11), was studied in the mouse mammary carcinoma FM3A cells. When the cells were treated with CPT-11 at a concentration of 5 micrograms/ml and 44 degrees C hyperthermia for 60 min, an enhancement of formation of single stand breaks (ssb) of DNA was observed. However, a decrease of ssb was observed when hyperthermia was combined with CPT-11 at 50 micrograms/ml. For inhibition of DNA synthesis additive effects were observed for treatment with CPT-11 at 5 micrograms/ml combined with hyperthermia. On the other hand, protective effects were observed for the combined treatment at 50 micrograms/ml. These results indicate that the hyperthermic modification of the effect of CPT-11 on the induction of DNA damage was diverse at low or high concentrations.
T Kondo, and
K Ueda, and
E Kano
January 1989,
Nucleic acids symposium series,
T Kondo, and
K Ueda, and
E Kano
June 1992,
Japanese journal of cancer research : Gann,
T Kondo, and
K Ueda, and
E Kano
January 1993,
Free radical research communications,
T Kondo, and
K Ueda, and
E Kano
October 1983,
The Journal of biological chemistry,
T Kondo, and
K Ueda, and
E Kano
May 1983,
International journal of radiation biology and related studies in physics, chemistry, and medicine,
T Kondo, and
K Ueda, and
E Kano
October 1985,
Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica,
T Kondo, and
K Ueda, and
E Kano
August 1981,
Radiation research,
T Kondo, and
K Ueda, and
E Kano
January 1988,
Nucleic acids symposium series,
T Kondo, and
K Ueda, and
E Kano
February 1989,
Cancer research,
T Kondo, and
K Ueda, and
E Kano
June 1987,
The Journal of biological chemistry,
